Elixia Joins SCRS Global Impact Partner Program
August 20, 2024 – Elixia, a leader in complex clinical research, has joined the Society for Clinical Research Sites (SCRS) as a new Global Impact Partner (GIP).
Elixia combines the robust capabilities of premier clinical research sites with a leading patient recruitment engine offering comprehensive solutions to sponsors and CROs. Elixia’s clinical research sites focus on cardiology/nephrology, psychiatry/neurology, complex metabolic and infectious disease across diverse patient populations spanning outpatient and inpatient settings. Elixia’s patient recruitment solutions, CSSi, uses both traditional and digital media to help find patients to participate in trials, while also offering site support through local enrollment specialists. This multifaceted approach offers sponsors and sites a variety of tactics that influence patient identification, recruitment and retention across geographies and demographics.
“The SCRS community contributes so much to advancements in clinical research,” said Dustin Owen, Elixia CEO. “We are privileged to become a Global Impact Partner, joining the community of leading site networks, sponsors, CROs, and solution providers. We look forward to working collaboratively to foster advancements that will benefit patients, sites, and sponsors.”
“SCRS is proud to welcome Elixia to the Global Impact Partner program,” shared Marcus Maleck, Vice President of Global Business Partnerships with SCRS. “Elixia’s expertise on trial agility will be invaluable as we work together to enhance the clinical trial process and support site sustainability. Their contributions will be instrumental in advancing the efficiency of clinical trials, benefiting sites and patients alike.”
The Global Impact Partnership offers industry sponsors, CROs, service providers and research sites an opportunity to align with SCRS’ mission of ensuring site sustainability. Elixia will provide input on strategic initiatives for the organization and contribute to SCRS events, committees, publications, advocacy and education for research sites. For more information on about the GIP Program, visit myscrs.org/industry-partnerships/global-impact-partners/.
About Elixia
Elixia is an industry-leading clinical research entity, linking a network of multi-site clinical research facilities with a global patient recruitment operation. With sites in California, Florida, Massachusetts, Missouri, Michigan, and Texas, Elixia conducts Phase I-IV studies, addressing complex conditions in metabolic health, nephrology, neuroscience, and infectious diseases. Elixia is renowned globally for its technological prowess, which enhances efficiency in patient acquisition and offers critical health outcome data that provides invaluable insights to sponsors worldwide. For more information, please visit elixiahealth.com.
About the Society for Clinical Research Sites (SCRS)
The Society for Clinical Research Sites (SCRS) is the leading advocacy organization dedicated to unifying the voice of the global clinical research site community. Representing more than 11,000 research sites in 54 countries, SCRS facilitates industry collaborations and conversations dedicated to site-focused advocacy, education, mentorship, and connection. SCRS is an active and influential champion for sites in industry initiatives to ensure that the perspective of sites is heard and valued. Learn more and get involved at myscrs.org. Our voice. Our community. Your success.
